Bioinformatics visualisation specialist Qlucore has released the beta version of its Qlucore Omics Explorer 3.3 software, including a completely new Next Generation Sequencing (NGS) Module and range of new functionalities for the base version. The NGS Module will enable additional functionality related to data generated with NGS technologies, making it possible to interactively and dynamically visualise, analyse and explore NGS data.
Qlucore Omics Explorer is a next-generation bioinformatics software program for broad usage known for its friendly user interface and advanced visualisation capabilities that enables biologists and researchers who are not data analysis experts to explore NGS and data, find new answers and generate new hypotheses.
Examples include RNA-seq studies, is one of the most used techniques in modern genetics and cancer research, with the NGS Module enabling a comprehensive and synchronised view of both expression levels and genomic locations. A unique flexibility is handed to the user, who can perform a statistical test in the expression space by simply moving a cut-off slider, observing the result in the Genome browser, one of the main components in the NGS Module which, in combination with the dynamic filters, ensures that the user always visualises the most interesting regions of the genome, minimising the need for zoom and scroll.
For further information on Qlucore and its new software visit www.qlucore.com
Latest from Tom Mulligan
- Diamond Pharma Services wins both Futures and Support categories at TOPRA Awards
- Droplet microfluidics offers new approach for studying plant cell biomechanics
- Catalent to open second clinical supply facility in China
- Arcis Biotechnology raises £1.25 million and opens further £0.5 million investment opportunity through Capital Cell
- Battery Ventures acquires TTP Labtech
- Scientists develop panel of recombinant human snake venom antibodies
- Avacta agrees Affimer reagent licensing deal with New England Biolabs
- Evonetix partners with LioniX International to enable DNA synthesis at scale
- TxCell terminates OCABSA financing programme following majority stake acquisition by Sangamo
- Kangstem Biotech selects MaSTherCell for GMP manufacturing of atopic dermatitis cell therapy in Europe